The proposed trial aimed to study the use of vadadustat to treat anemia in patients with late-stage chronic kidney disease not on dialysis. The treatment is already approved for such patients who have ...

The iron deficiency anemia therapy market is propelled by the increasing cases of IDA, majorly in women, children, and the ...

Shares of Akebia Therapeutics fell sharply premarket after it abandoned plans for a clinical trial of its anemia treatment in patients not on kidney dialysis following a meeting with the Food and Drug ...

Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.

Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

Soft Tissue Infections Following Parenteral Injection in Children Aged 0 to 15 Years at the Mother and Child University ...

Disc Medicine, Inc. (($IRON)) announced an update on their ongoing clinical study. Disc Medicine, Inc. is conducting a study titled RALLY-MF: A ...

A Gurugram hospital team removed a 10-kilogram abdominal tumor from a 39-year-old Jammu and Kashmir woman. The tumor had ...

Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization ...

Researchers have developed a new iron supplement that pairs iron with prebiotics and probiotics to improve absorption and reduce side effects. Iron-deficiency anemia is a widespread condition that ...